Modulation of Lipoprotein Cholesterol Levels in Plasmodium berghei Malarial Infection by Crude Aqueous Extract of Ganoderma lucidum

Table 2

Serum TC, LDL-, HDL-, and VLDL-cholesterol levels in mice Plasmodium berghei infected mice treated with aqueous extract of Ganoderma lucidum.

Treatment groups		TC	LDL	HDL	VLDL
Controls	Normal	8.75 ± 0.86^a	5.29 ± 0.57^a	1.46 ± 0.01^a	2.01 ± 0.01^a
	Infected	68.43 ± 5.33^b	36.56 ± 5.64^b	16.14 ± 0.01^b	15.74 ± 0.01^b
Aqueous extract	AQ100	33.76 ± 2.27^c	21.77 ± 1.47^c	3.88 ± 0.01^c	8.10 ± 0.17^c
	AQ250	39.97 ± 1.29^c	25.58 ± 0.83^c	4.40 ± 0.01^d	9.99 ± 0.06^d
	AQ500	63.87 ± 5.03^b	40.87 ± 3.22^b	8.33 ± 0.01^e	14.69 ± 0.01^e
Reference drug	CQ	66.17 ± 4.50^b	39.86 ± 2.40^b	10.43 ± 0.01^f	15.88 ± 0.02^b

Results are means ± SEM of eight independent determinations. Values in the same row carrying different superscripts are significant (𝑃<0.05) from each other.
Note. P-CTR: positive control mice; N-CTR: negative control mice; AQ₁₀₀: infected group treated with 100 mg/kg G. lucidum; AQ₂₅₀: infected group treated with 250 mg/kg G. lucidum; AQ₅₀₀: infected mice treated with 500 mg/kg G. lucidum; CQ: infected mice treated with chloroquine.